BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26088612)

  • 1. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
    Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
    Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic tumefactive demyelination in a 47-year-old man with underlying seminoma.
    Van Haver AS; Debruyne F; Sanders K; Verstappen A
    Mult Scler Relat Disord; 2020 Jul; 42():102060. PubMed ID: 32217464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma.
    Thebault S; Hanes I; Woulfe J; Bourque PR
    Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e527. PubMed ID: 30588483
    [No Abstract]   [Full Text] [Related]  

  • 4. Solitary focal demyelination in the brain as a paraneoplastic disorder.
    Jaster JH; Bertorini TE; Dohan FC; O'Brien TF; Wang H; Becske T; Menke PG; Handorf CR; Horner LH; Mönkemüller KE
    Med Pediatr Oncol; 1996 Feb; 26(2):111-5. PubMed ID: 8531848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination.
    DeVito N; Mui K; Jassam Y; Taylor L; Pilichowska M; Cossor F
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e131-5. PubMed ID: 24630921
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumefactive demyelination of the spinal cord.
    Yaghi S; Gokdin M; Sethi H
    Acta Neurol Belg; 2010 Jun; 110(2):206-8. PubMed ID: 20873455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma.
    Shiraishi W; Umemura T; Nakayama Y; Yamada Y; Shijo M; Hashimoto T
    Front Neurol; 2022; 13():946180. PubMed ID: 35899265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary tumefactive demyelinating lesions in children.
    Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
    J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudotumoral demyelination: a diagnosis pitfall (report of three cases).
    Heyman D; Delhaye M; Fournier D; Mercier P; Rousselet MC; Menei P
    J Neurooncol; 2001 Aug; 54(1):71-6. PubMed ID: 11763425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric tumefactive demyelination: case series and review of the literature.
    McAdam LC; Blaser SI; Banwell BL
    Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.
    Kepes JJ
    Ann Neurol; 1993 Jan; 33(1):18-27. PubMed ID: 8494332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
    Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
    J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
    Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
    J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing Tumefactive Demyelination: A Case Report.
    Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
    Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.
    Ng S; Butzkueven H; Kalnins R; Rowe C
    J Clin Neurosci; 2007 Nov; 14(11):1126-9. PubMed ID: 17890092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tumefactive inflammatory demyelination in a child.
    Hinnell CJ; Lu JQ; Rajapakse T; Mah JK
    Pediatr Neurol; 2011 May; 44(5):394-5. PubMed ID: 21481752
    [No Abstract]   [Full Text] [Related]  

  • 18. Demyelination preceding a diagnosis of central nervous system lymphoma.
    Kalus S; Di Muzio B; Gaillard F
    J Clin Neurosci; 2016 Feb; 24():146-8. PubMed ID: 26455545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial numbness in a man with inguinal and retroperitoneal masses.
    Plotkin SR; Dorfman MV; Loeffler JS
    Nat Clin Pract Oncol; 2005 Jan; 2(1):54-8; quiz 1 p following 58. PubMed ID: 16264857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme masquerading as a tumefactive demyelinating lesion: Lessons learned at autopsy.
    Gupta K; Mehta S; Ahuja CK; Salunke P; Sharma N
    Neurol India; 2016; 64(4):737-41. PubMed ID: 27381122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.